力学 发表于 2025-3-21 17:54:17

书目名称Breast Cancer影响因子(影响力)<br>        http://impactfactor.cn/if/?ISSN=BK0190554<br><br>        <br><br>书目名称Breast Cancer影响因子(影响力)学科排名<br>        http://impactfactor.cn/ifr/?ISSN=BK0190554<br><br>        <br><br>书目名称Breast Cancer网络公开度<br>        http://impactfactor.cn/at/?ISSN=BK0190554<br><br>        <br><br>书目名称Breast Cancer网络公开度学科排名<br>        http://impactfactor.cn/atr/?ISSN=BK0190554<br><br>        <br><br>书目名称Breast Cancer被引频次<br>        http://impactfactor.cn/tc/?ISSN=BK0190554<br><br>        <br><br>书目名称Breast Cancer被引频次学科排名<br>        http://impactfactor.cn/tcr/?ISSN=BK0190554<br><br>        <br><br>书目名称Breast Cancer年度引用<br>        http://impactfactor.cn/ii/?ISSN=BK0190554<br><br>        <br><br>书目名称Breast Cancer年度引用学科排名<br>        http://impactfactor.cn/iir/?ISSN=BK0190554<br><br>        <br><br>书目名称Breast Cancer读者反馈<br>        http://impactfactor.cn/5y/?ISSN=BK0190554<br><br>        <br><br>书目名称Breast Cancer读者反馈学科排名<br>        http://impactfactor.cn/5yr/?ISSN=BK0190554<br><br>        <br><br>

misshapen 发表于 2025-3-21 22:54:52

http://reply.papertrans.cn/20/1906/190554/190554_2.png

男生如果明白 发表于 2025-3-22 02:13:10

http://reply.papertrans.cn/20/1906/190554/190554_3.png

事与愿违 发表于 2025-3-22 04:57:17

http://reply.papertrans.cn/20/1906/190554/190554_4.png

AXIS 发表于 2025-3-22 11:53:46

http://reply.papertrans.cn/20/1906/190554/190554_5.png

Urgency 发表于 2025-3-22 16:52:04

http://reply.papertrans.cn/20/1906/190554/190554_6.png

Extricate 发表于 2025-3-22 19:47:42

http://reply.papertrans.cn/20/1906/190554/190554_7.png

groggy 发表于 2025-3-23 00:08:17

Hasnaa Bouharoun-Tayoun,Pierre Druilhettle or no benefit from additional adjuvant chemotherapy. MammaPrint is a recently approved multigene assay that can assist in predicting the prognosis of women with stage I or II, lymph node-negative breast cancer. The most appropriate treatment decisions often require integration of prognostic and

obscurity 发表于 2025-3-23 04:13:33

https://doi.org/10.1007/978-94-009-6042-8he past 6 years, more than 22 phase III clinical trials of HDC with AHST have been conducted and reported to date. The results are conflicting: some results are positive and others are negative. The safety and tolerability of HDC with AHST for breast cancer have improved greatly over the last decade

Enrage 发表于 2025-3-23 09:16:23

http://reply.papertrans.cn/20/1906/190554/190554_10.png
页: [1] 2 3 4 5 6 7
查看完整版本: Titlebook: Breast Cancer; Kelly K. Hunt,Geoffrey L. Robb,Naoto T. Ueno Book 2008Latest edition Springer-Verlag New York 2008 Internist.biopsy.breast